To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RABEPKTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
267 supporting clones for gene RABEPK back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BI116041 lung, small cell carcinoma .a 1 to 810 1 to 806   tiling clone,   806/807
(99 %)
17 diff
(97.9 %id)
BU602888 mixed (pool of 40 RNAs) .a 1 to 842 1 to 844       844/845
(99 %)
15 diff
(98.3 %id)
BP245771 Kidney .a 2 to 593 1 to 592       592/592
(100 %)
3 diff
(99.5 %id)
CX758286 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 2 to 726 1 to 723     Submitted on the opposite strand 723/723
(100 %)
3 diff
(99.6 %id)
NM_005833.3   .a 2 to 1628 1 to 1627 exact RefSeq, AAA   1627/1627
(100 %)
0 diff
(100 %id)
BG528283 lung, mucoepidermoid carcinoma .a 3 to 671 1 to 664       664/683
(97 %)
12 diff
(98.3 %id)
BU147135 brain, neuroblastoma, cell line .a 5 to 908 1 to 913       910/939
(96 %)
17 diff
(98.2 %id)
CR616433 Neuroblastoma Cot 25-normalized .a 7 to 1492 1 to 1486 exact     1486/1486
(100 %)
0 diff
(100 %id)
BX376141 Neuroblastoma Cot 25-normalized .a 7 to 791 1 to 786   fully sequenced,   786/786
(100 %)
2 diff
(99.8 %id)
BG746948 adenocarcinoma cell line, colon .a 9 to 781 1 to 772       772/772
(100 %)
5 diff
(99.4 %id)
BQ069406 brain, neuroblastoma, cell line .a 11 to 807 9 to 819       809/1151
(70 %)
26 diff
(97.8 %id)
BQ717852 sympathetic trunk .a 11 to 915 1 to 908       908/913
(99 %)
12 diff
(98.7 %id)
BE743954 adenocarcinoma cell line, ovary .a 13 to 807 1 to 785       785/790
(99 %)
25 diff
(96.9 %id)
BX388127   .a 14 to 791 1 to 776   fully sequenced,   776/776
(100 %)
8 diff
(99.0 %id)
CR624302 B cells (Ramos cell line) Cot 25-normalized .a 15 to 1458 1 to 1444 exact     1444/1444
(100 %)
0 diff
(100 %id)
BQ060098 lymph, lymphoma, cell line .a 15 to 855 20 to 869       850/995
(85 %)
28 diff
(97.2 %id)
BQ646024 hepatocellular carcinoma, cell line, Liver .a 15 to 801 18 to 817       800/880
(90 %)
21 diff
(97.7 %id)
CN292954 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 18 to 272 1 to 256       256/260
(98 %)
2 diff
(99.3 %id)
BE391766 endometrium, adenocarcinoma cell line, uterus .a 18 to 695 26 to 703       678/755
(89 %)
12 diff
(98.5 %id)
BE391687 endometrium, adenocarcinoma cell line, uterus .a 19 to 695 13 to 687       675/713
(94 %)
13 diff
(98.2 %id)
BF220334 lung, small cell carcinoma .a 22 to 685 28 to 691       664/691
(96 %)
9 diff
(98.7 %id)
BF306293 muscle, rhabdomyosarcoma .a 23 to 695 1 to 666       666/966
(68 %)
12 diff
(98.8 %id)
BC000503 Lung, small cell carcinoma .a 25 to 1472 1 to 1448 H73Y D313G available from MGC, AAA   1448/1448
(100 %)
4 diff
(99.8 %id)
CR616448 fetal brain .a 27 to 1595 1 to 1569 exact tiling clone,   1569/1569
(100 %)
0 diff
(100 %id)
BX442612 brain, fetal brain .a 27 to 888 1 to 860   fully sequenced,   860/860
(100 %)
1 diff
(99.9 %id)
BE410893 choriocarcinoma, placenta .a 31 to 736 1 to 706       706/771
(91 %)
13 diff
(98.4 %id)
BQ943753 large cell carcinoma, lung .a 35 to 807 43 to 825       783/1009
(77 %)
23 diff
(97.8 %id)
BG334701 melanotic melanoma, skin .a 39 to 746 1 to 705       705/972
(72 %)
12 diff
(98.8 %id)
BG475092 melanotic melanoma, skin .a 39 to 849 1 to 810       810/811
(99 %)
10 diff
(98.8 %id)
BE410970 choriocarcinoma, placenta .a 47 to 695 1 to 650       650/659
(98 %)
10 diff
(98.5 %id)
BM462349 leiomyosarcoma, uterus .a 63 to 839 1 to 792   AAA   792/1111
(71 %)
24 diff
(97.9 %id)
BM712877 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 84 to 609 1 to 526       526/526
(100 %)
1 diff
(99.9 %id)
BE618124 eye, retinoblastoma .a 127 to 637 1 to 511       511/511
(100 %)
1 diff
(99.9 %id)
BX376140 Neuroblastoma Cot 25-normalized .a 761 to 1492 731 to 1   fully sequenced,   731/731
(100 %)
15 diff
(98.0 %id)
BX388126   .a 761 to 1458 697 to 1   fully sequenced,   697/697
(100 %)
3 diff
(99.6 %id)
BX442611 brain, fetal brain .a 827 to 1595 769 to 1   fully sequenced,   769/769
(100 %)
2 diff
(99.8 %id)
BP309824 brain .b 1 to 580 1 to 580   tiling clone,   580/583
(99 %)
3 diff
(99.5 %id)
BG703890 brain, hippocampus .b 19 to 675 1 to 657       657/657
(100 %)
5 diff
(99.3 %id)
BC065725 Bone marrow, chronic myelogenous leukemia .b 20 to 1336 1 to 1317 R60G tiling clone, available from MGC, AAA   1317/1317
(100 %)
2 diff
(99.9 %id)
BU600178 mixed (pool of 40 RNAs) .b 21 to 715 1 to 699       699/758
(92 %)
9 diff
(98.9 %id)
BF209775 bone marrow, from chronic myelogenous leukemia .b 23 to 552 1 to 536       536/907
(59 %)
30 diff
(96.7 %id)
CB991596 placenta, pre-eclamptic placenta .b 23 to 440 28 to 445       418/467
(89 %)
7 diff
(98.6 %id)
CB994923 placenta, pre-eclamptic placenta .b 23 to 715 28 to 725       698/802
(87 %)
29 diff
(96.4 %id)
CB997884 placenta, pre-eclamptic placenta .b 23 to 661 28 to 670       643/817
(78 %)
16 diff
(98.1 %id)
CB961659 placenta, pre-eclamptic placenta .b 23 to 715 28 to 724       697/775
(89 %)
14 diff
(98.2 %id)
NM_001174152.1   .b 23 to 1488 1 to 1466 exact RefSeq, AAA   1466/1466
(100 %)
0 diff
(100 %id)
AV759039 bone marrow .b 25 to 819 1 to 785       785/785
(100 %)
13 diff
(98.4 %id)
AW068782 Bone, Hip .b 26 to 476 1 to 453       453/453
(100 %)
5 diff
(98.9 %id)
BP229602 brain .b 29 to 610 1 to 582       582/582
(100 %)
7 diff
(98.8 %id)
BP330018 rectum .b 29 to 614 1 to 586       586/586
(100 %)
1 diff
(99.9 %id)
CD691129 normal nasopharynx .b 31 to 651 40 to 660       621/660
(94 %)
8 diff
(98.8 %id)
BM926132 brain .b 31 to 869 1 to 839       839/1028
(81 %)
7 diff
(99.4 %id)
CR607227 T cells (Jurkat cell line) .b 33 to 1322 1 to 1290 exact     1290/1290
(100 %)
0 diff
(100 %id)
BX462531 T cells (Jurkat cell line) .b 33 to 869 1 to 837       837/946
(88 %)
1 diff
(99.9 %id)
AA314415 colon .b 35 to 436 1 to 402       402/402
(100 %)
1 diff
(99.8 %id)
BP256852 Kidney .b 36 to 617 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
BM797607 Ascites, stomach .b 37 to 507 1 to 471       471/471
(100 %)
1 diff
(99.8 %id)
BI256695 cervical carcinoma cell line, cervix .b 38 to 850 1 to 823       823/823
(100 %)
23 diff
(97.3 %id)
DA731739   .b 38 to 831 2 to 799   capped   798/837
(95 %)
22 diff
(97.4 %id)
BP355016   .b 39 to 626 1 to 587       587/587
(100 %)
2 diff
(99.7 %id)
BU581453 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .b 40 to 595 1 to 556       556/563
(98 %)
4 diff
(99.3 %id)
BX106671 brain .b 40 to 717 1 to 678       678/688
(98 %)
1 diff
(99.9 %id)
H20945 brain .b 40 to 466 1 to 435       435/460
(94 %)
17 diff
(96.4 %id)
BG696128 skin .b 40 to 828 1 to 801       799/807
(99 %)
20 diff
(97.6 %id)
BI258889 cervical carcinoma cell line, cervix .b 40 to 802 1 to 763       763/763
(100 %)
1 diff
(99.9 %id)
BE410212 choriocarcinoma, placenta .b 41 to 822 1 to 785       783/786
(99 %)
9 diff
(98.9 %id)
BY799007 eye .b 42 to 651 1 to 610       610/610
(100 %)
0 diff
(100 %id)
BG333667 melanotic melanoma, skin .b 42 to 852 1 to 808       808/916
(88 %)
28 diff
(97.0 %id)
BG334944 melanotic melanoma, skin .b 42 to 667 1 to 636       636/636
(100 %)
15 diff
(97.7 %id)
BG478803 melanotic melanoma, skin .b 42 to 868 1 to 829       829/1018
(81 %)
9 diff
(99.2 %id)
CD513425 brain, Pituitary .b 43 to 832 1 to 795       795/890
(89 %)
14 diff
(98.5 %id)
Z97074   .b 44 to 1329 1 to 1287 A329V AAA   1287/1287
(100 %)
4 diff
(99.7 %id)
CB137374 Liver .b 47 to 539 1 to 493       493/493
(100 %)
0 diff
(100 %id)
AK290768   .b 49 to 1329 32 to 1312 exact     1281/1281
(100 %)
0 diff
(100 %id)
DA618584   .b 49 to 422 32 to 405   capped   374/374
(100 %)
0 diff
(100 %id)
BQ422419 large cell carcinoma, lung .b 50 to 896 11 to 864       854/864
(98 %)
14 diff
(98.4 %id)
TI_57238741   .b 50 to 842 58 to 849       792/849
(93 %)
8 diff
(99.1 %id)
BE548122 cervical carcinoma cell line, cervix .b 51 to 810 1 to 746       746/885
(84 %)
24 diff
(97.3 %id)
CB160790 Liver .b 51 to 642 1 to 592       592/592
(100 %)
0 diff
(100 %id)
BC053541 Ovary, pooled from 3 adults .b 53 to 1488 1 to 1436 exact tiling clone, available from MGC, AAA   1436/1436
(100 %)
0 diff
(100 %id)
BM547493 ovary (pool of 3) .b 53 to 1008 1 to 959       959/1108
(86 %)
19 diff
(98.3 %id)
BE255130 eye, retinoblastoma .b 54 to 673 1 to 615       615/676
(90 %)
11 diff
(98.4 %id)
BE255964 eye, retinoblastoma .b 56 to 630 1 to 577       577/579
(99 %)
6 diff
(99.0 %id)
CX755176 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 57 to 788 1 to 732     Submitted on the opposite strand 732/732
(100 %)
2 diff
(99.8 %id)
BQ212248 melanotic melanoma, skin .b 61 to 913 1 to 856       856/872
(98 %)
10 diff
(98.9 %id)
BE384076 melanotic melanoma, skin .b 62 to 662 1 to 601       601/601
(100 %)
1 diff
(99.9 %id)
BE296280 muscle, rhabdomyosarcoma .b 71 to 717 1 to 646       646/731
(88 %)
9 diff
(98.8 %id)
BE295208 muscle, rhabdomyosarcoma .b 71 to 529 1 to 459       459/459
(100 %)
1 diff
(99.8 %id)
BE269777 Burkitt lymphoma, lymph .b 71 to 651 1 to 581       581/582
(99 %)
1 diff
(99.9 %id)
BE270409 Burkitt lymphoma, lymph .b 71 to 646 1 to 576       576/576
(100 %)
0 diff
(100 %id)
BE315343 adenocarcinoma cell line, ovary .b 73 to 658 1 to 586       586/586
(100 %)
0 diff
(100 %id)
N36641 melanocyte .b 74 to 661 1 to 599       599/616
(97 %)
21 diff
(96.6 %id)
BF971267 adrenal cortex carcinoma, cell line, adrenal gland .b 76 to 867 1 to 788       788/859
(91 %)
17 diff
(98.1 %id)
BQ939810 epidermoid carcinoma, cell line, lung .b 76 to 962 35 to 926       892/928
(96 %)
20 diff
(97.9 %id)
BF683061 leiomyosarcoma cell line, uterus .b 78 to 717 1 to 644       644/819
(78 %)
12 diff
(98.6 %id)
BG338816 leiomyosarcoma cell line, uterus .b 78 to 882 1 to 804       804/995
(80 %)
35 diff
(96.5 %id)
BG339048 leiomyosarcoma cell line, uterus .b 78 to 831 1 to 747       747/972
(76 %)
13 diff
(98.7 %id)
BE208119 carcinoma cell line, cervix .b 81 to 544 1 to 464     Submitted on the opposite strand 464/465
(99 %)
21 diff
(95.5 %id)
BE388932 endometrium, adenocarcinoma cell line, uterus .b 103 to 753 1 to 653       653/653
(100 %)
3 diff
(99.6 %id)
BE409255 choriocarcinoma, placenta .b 103 to 766 1 to 657       657/689
(95 %)
12 diff
(98.3 %id)
AA324698 brain, cerebellum .b 170 to 434 1 to 268       264/268
(98 %)
5 diff
(98.2 %id)
TI_1948092884   .b 191 to 807 121 to 737   fully sequenced,   613/733
(83 %)
7 diff
(99.1 %id)
TI_1948225695   .b 191 to 717 124 to 650       523/1418
(36 %)
8 diff
(99.5 %id)
TI_1948225841   .b 191 to 807 125 to 741   fully sequenced,   613/737
(83 %)
7 diff
(99.1 %id)
TI_1948225988   .b 191 to 821 125 to 754   fully sequenced,   626/750
(83 %)
9 diff
(98.8 %id)
TI_1948226136   .b 191 to 807 119 to 735   fully sequenced,   613/731
(83 %)
7 diff
(99.1 %id)
CR456837   .b 192 to 1310 1 to 1119 H73Y     1119/1119
(100 %)
2 diff
(99.9 %id)
CR541851   .b 192 to 1307 1 to 1116       1116/1116
(100 %)
1 diff
(100.0 %id)
CV026123 mixed .b 192 to 808 1 to 617       617/617
(100 %)
1 diff
(99.9 %id)
EL735885 mixed .b 192 to 846 1 to 655       655/655
(100 %)
2 diff
(99.7 %id)
CR608411 Neuroblastoma Cot 25-normalized .b 194 to 1321 1 to 1128       1128/1128
(100 %)
0 diff
(100 %id)
AL523478 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 194 to 748 1 to 554   fully sequenced,   554/554
(100 %)
2 diff
(99.7 %id)
CF146923 CNCAP(3)T-225 cell line, Prostate .b 206 to 893 5 to 694       690/694
(99 %)
7 diff
(99.0 %id)
TI_154179752   .b 210 to 1017 77 to 880       804/815
(98 %)
11 diff
(98.7 %id)
CF147166 CNCAP(3)T-225 cell line, Prostate .b 212 to 879 10 to 680       667/680
(98 %)
7 diff
(99.0 %id)
TI_154179464   .b 212 to 1017 81 to 891       807/821
(98 %)
9 diff
(99.0 %id)
BM807424 amelanotic melanoma, cell line, skin .b 229 to 950 1 to 740       736/1048
(70 %)
27 diff
(97.5 %id)
AA092847   .b 237 to 622 1 to 377       377/407
(92 %)
13 diff
(96.9 %id)
BI256257 cervical carcinoma cell line, cervix .b 254 to 1122 1 to 874       874/1097
(79 %)
10 diff
(99.1 %id)
BM823858 Ascites, stomach .b 310 to 869 1 to 560       560/570
(98 %)
5 diff
(99.2 %id)
CN292953 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 329 to 1098 1 to 770       770/770
(100 %)
1 diff
(99.9 %id)
BQ328825 lung_normal .b 356 to 475 4 to 123       120/123
(97 %)
10 diff
(91.9 %id)
BE709063 head_neck .b 360 to 703 349 to 1       349/350
(99 %)
24 diff
(93.2 %id)
CN292950 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 362 to 869 1 to 509       509/515
(98 %)
2 diff
(99.7 %id)
CN292952 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 370 to 1096 1 to 728       728/728
(100 %)
2 diff
(99.8 %id)
BU181782 eye, retinoblastoma .b 402 to 1209 13 to 822       810/822
(98 %)
11 diff
(98.7 %id)
TI_59393306   .b 407 to 1245 83 to 924       842/851
(98 %)
14 diff
(98.4 %id)
BM015182 breast, mammary adenocarcinoma, cell line .b 408 to 1245 1 to 841       841/850
(98 %)
14 diff
(98.4 %id)
FN066984 breast carcinoma .b 436 to 501 1 to 65       65/66
(98 %)
2 diff
(97.0 %id)
BI093203 cervix .b 453 to 1225 1 to 771       771/772
(99 %)
7 diff
(99.1 %id)
BG388113 embryonal carcinoma, cell line, testis .b 460 to 1126 1 to 665       665/838
(79 %)
13 diff
(98.5 %id)
CR590651 B cells (Ramos cell line) Cot 25-normalized .b 495 to 1330 1 to 836       836/836
(100 %)
0 diff
(100 %id)
BX384714   .b 495 to 1330 1 to 836   fully sequenced,   836/836
(100 %)
0 diff
(100 %id)
W52527 senescent fibroblast .b 504 to 1107 1 to 611       611/612
(99 %)
12 diff
(98.1 %id)
BE175058 head_neck .b 527 to 703 1 to 178       178/178
(100 %)
5 diff
(97.2 %id)
AL523477 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 687 to 1321 635 to 1   fully sequenced,   635/635
(100 %)
13 diff
(98.0 %id)
BX363453   .b 687 to 1300 614 to 1   fully sequenced,   614/614
(100 %)
22 diff
(96.5 %id)
TI_1948092885   .b 777 to 1314 660 to 123   fully sequenced,   538/660
(81 %)
0 diff
(100 %id)
TI_1948225842   .b 777 to 1314 657 to 119   fully sequenced,   539/657
(82 %)
0 diff
(100 %id)
TI_1948226137   .b 777 to 1314 653 to 115   fully sequenced,   539/653
(82 %)
0 diff
(100 %id)
TI_1948225989   .b 791 to 1314 646 to 119   fully sequenced,   528/646
(81 %)
3 diff
(99.6 %id)
BX414149 T cells (Jurkat cell line) .b 868 to 1322 454 to 1       454/607
(74 %)
8 diff
(98.7 %id)
H20946 brain .b 940 to 1325 390 to 1       390/395
(98 %)
4 diff
(99.0 %id)
N26009 melanocyte .b 1196 to 1336 163 to 23   AAA   141/141
(100 %)
0 diff
(100 %id)
CR600864 T cells (Jurkat cell line) Cot10-normalized .c 1 to 1130 1 to 1130   tiling clone,   1130/1130
(100 %)
0 diff
(100 %id)
DW422145 Liver .c 5 to 286 14 to 295       282/295
(95 %)
6 diff
(98.0 %id)
NM_001174153.1   .c 8 to 1320 1 to 1313 exact RefSeq, AAA   1313/1313
(100 %)
0 diff
(100 %id)
CB129685 Liver .c 14 to 426 1 to 413       413/413
(100 %)
1 diff
(99.8 %id)
CB145009 Liver .c 14 to 298 1 to 285       285/285
(100 %)
1 diff
(99.7 %id)
BP429987   .c 14 to 341 1 to 328       328/328
(100 %)
2 diff
(99.4 %id)
BX383417   .c 16 to 418 18 to 420   fully sequenced,   403/420
(95 %)
6 diff
(98.6 %id)
H85272 melanocyte .c 17 to 361 1 to 345       345/351
(98 %)
13 diff
(96.3 %id)
BU601253 mixed (pool of 40 RNAs) .c 20 to 761 1 to 755       755/865
(87 %)
28 diff
(96.8 %id)
CD621266   .c 21 to 213 1 to 193       193/196
(98 %)
3 diff
(98.5 %id)
AU099366   .c 21 to 320 1 to 300       300/300
(100 %)
2 diff
(99.4 %id)
CD621267   .c 23 to 213 210 to 22       189/225
(84 %)
2 diff
(99.2 %id)
BQ683973 melanotic melanoma, cell line, skin .c 27 to 843 1 to 826       826/945
(87 %)
15 diff
(98.5 %id)
BU839055 melanotic melanoma, cell line, skin .c 27 to 847 1 to 823       823/963
(85 %)
13 diff
(98.7 %id)
TI_57190780   .c 27 to 896 53 to 956       851/904
(94 %)
46 diff
(95.0 %id)
BC047023 Breast, mammary adenocarcinoma. .c 28 to 1168 1 to 1141 exact tiling clone, available from MGC, AAA   1141/1141
(100 %)
0 diff
(100 %id)
BI859312 breast, mammary adenocarcinoma, cell line .c 29 to 896 1 to 902       849/902
(94 %)
46 diff
(95.0 %id)
W24464 lung .c 36 to 299 31 to 292       262/292
(89 %)
6 diff
(98.0 %id)
CD693254 normal nasopharynx .c 144 to 537 1 to 393       393/393
(100 %)
3 diff
(99.3 %id)
AI435130 pooled .c 207 to 1159 471 to 3       463/471
(98 %)
2 diff
(99.6 %id)
BX383416   .c 357 to 1130 775 to 1   fully sequenced,   775/775
(100 %)
4 diff
(99.5 %id)
AA373340 lung .c 407 to 701 1 to 295       295/295
(100 %)
1 diff
(99.7 %id)
AW957473   .c 408 to 838 1 to 431       431/432
(99 %)
1 diff
(99.8 %id)
AA745106 Ewing's sarcoma .c 472 to 805 70 to 407       338/407
(83 %)
18 diff
(95.6 %id)
AI857507 anaplastic oligodendroglioma, brain .c 550 to 1161 612 to 1       612/772
(79 %)
2 diff
(99.8 %id)
AW249542 lung, small cell carcinoma .c 575 to 1155 596 to 16       581/596
(97 %)
0 diff
(100 %id)
BG231799 blood, lymphocyte .c 625 to 1157 535 to 3       533/536
(99 %)
10 diff
(98.2 %id)
AI339627 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 645 to 1162 518 to 4       515/518
(99 %)
4 diff
(99.3 %id)
BQ669765 epidermoid carcinoma, cell line, salivary gland .c 645 to 1161 13 to 529   AAA   517/529
(97 %)
6 diff
(98.9 %id)
AI189670 placenta .c 650 to 1219 567 to 1       567/570
(99 %)
8 diff
(98.6 %id)
AW603102 breast .c 656 to 894 238 to 2       237/239
(99 %)
2 diff
(99.2 %id)
AA834595 germinal center B cell .c 657 to 1161 539 to 34   AAA   506/506
(100 %)
2 diff
(99.7 %id)
AA946850 2 pooled tumors (clear cell type), Kidney .c 657 to 1159 506 to 3       504/506
(99 %)
1 diff
(99.9 %id)
AA724914 parathyroid gland, parathyroid tumor .c 675 to 1220 549 to 6       544/549
(99 %)
10 diff
(98.2 %id)
CA442661 lung, Lung Focal Fibrosis .c 679 to 1168 507 to 19   AAA   489/491
(99 %)
5 diff
(99.0 %id)
AA812016 germinal center B cell .c 684 to 1161 496 to 17   AAA   480/480
(100 %)
8 diff
(98.4 %id)
AI160112 brain, glioblastoma (pooled) .c 696 to 1169 479 to 6       474/479
(98 %)
0 diff
(100 %id)
N92286 lung .c 698 to 1158 468 to 1       468/471
(99 %)
10 diff
(97.9 %id)
TI_45235620   .c 699 to 1220 63 to 583   AAA   521/1091
(47 %)
8 diff
(99.3 %id)
AI359293 brain, glioblastoma (pooled) .c 700 to 1168 469 to 1       469/469
(100 %)
0 diff
(100 %id)
TI_154031021   .c 700 to 1168 548 to 81   AAA   468/770
(60 %)
1 diff
(99.9 %id)
BG206554   .c 704 to 1139 438 to 4     Submitted on the opposite strand 435/438
(99 %)
0 diff
(100 %id)
BI517368 pooled colon, kidney, stomach .c 704 to 1216 1 to 512   AAA   512/512
(100 %)
1 diff
(99.9 %id)
AI539066 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .c 705 to 1162 455 to 1       455/455
(100 %)
7 diff
(98.5 %id)
BF109071 pooled .c 717 to 1159 446 to 4       443/446
(99 %)
9 diff
(98.0 %id)
AA563683 colon .c 720 to 1168 449 to 1       449/449
(100 %)
0 diff
(100 %id)
AI246162 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 723 to 1159 439 to 3       437/439
(99 %)
0 diff
(100 %id)
BM708027 eye, RPE and Choroid .c 726 to 1161 1 to 436   fully sequenced, AAA   436/436
(100 %)
1 diff
(99.8 %id)
AW080123 esophagus, squamous cell carcinoma .c 729 to 1162 434 to 1       434/434
(100 %)
1 diff
(99.8 %id)
AA644050 colon, colon tumor RER+ .c 732 to 1161 430 to 1       430/435
(98 %)
0 diff
(100 %id)
BF436326 fibrotheoma, ovary .c 759 to 1158 414 to 15   AAA   400/400
(100 %)
1 diff
(99.8 %id)
BU581152 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .c 764 to 1215 452 to 1       452/452
(100 %)
1 diff
(99.8 %id)
BM811375 ovary (pool of 3) .c 773 to 1168 18 to 413   AAA   396/413
(95 %)
6 diff
(98.6 %id)
AA825252 carcinoid, lung .c 780 to 1216 437 to 1       437/437
(100 %)
1 diff
(99.8 %id)
AA829410 germinal center B cell .c 783 to 855 73 to 1       73/73
(100 %)
4 diff
(94.6 %id)
EL951070 eyeball .c 802 to 1168 47 to 413   AAA   367/414
(88 %)
12 diff
(97.2 %id)
AW090606 brain, tumor, 5 pooled (see description) .c 807 to 1162 358 to 2       357/360
(99 %)
4 diff
(98.9 %id)
H84815 melanocyte .c 809 to 1140 332 to 1       332/341
(97 %)
2 diff
(99.5 %id)
BG202475   .c 815 to 1111 298 to 2     Submitted on the opposite strand 297/298
(99 %)
0 diff
(100 %id)
BE872008 adenocarcinoma, colon .c 822 to 1166 1 to 345       345/345
(100 %)
3 diff
(99.2 %id)
FN069886 breast carcinoma .c 830 to 929 1 to 100       100/100
(100 %)
1 diff
(99.0 %id)
FN098644 breast carcinoma .c 834 to 932 1 to 99       99/100
(99 %)
3 diff
(97.0 %id)
BF760906 colon_est .c 851 to 993 145 to 1     Submitted on the opposite strand 145/163
(88 %)
5 diff
(97.0 %id)
BG272752 nasopharynx, normal epithelium .c 855 to 1169 323 to 8       316/323
(97 %)
0 diff
(100 %id)
AW068520 Bone, Hip .c 870 to 1157 295 to 8       288/295
(97 %)
0 diff
(100 %id)
BU731427 eye, RPE and Choroid .c 874 to 1162 306 to 18   fully sequenced,   289/306
(94 %)
1 diff
(99.7 %id)
AI419208 brain, glioblastoma (pooled) .c 883 to 1168 286 to 1       286/286
(100 %)
20 diff
(93.1 %id)
BE858952 Prostate .c 897 to 1137 241 to 1       241/241
(100 %)
5 diff
(98.0 %id)
AA911957 adenocarcinoma, colon .c 912 to 1220 313 to 5       309/313
(98 %)
0 diff
(100 %id)
FN168841 breast carcinoma .c 940 to 1023 1 to 86       86/90
(95 %)
4 diff
(95.6 %id)
AW292711   .c 948 to 1216 286 to 18   AAA   269/269
(100 %)
7 diff
(97.4 %id)
GD142596   .c 1039 to 1161 1 to 123   AAA   123/123
(100 %)
3 diff
(97.6 %id)
DB448374 testis .d 1 to 422 1 to 423   tiling clone,   423/423
(100 %)
23 diff
(94.6 %id)
BG696326 skin .d 329 to 1282 1 to 949   tiling clone, AAA   949/949
(100 %)
25 diff
(97.4 %id)
TI_227714549   .d 349 to 1271 1006 to 103   AAA   904/987
(91 %)
22 diff
(97.8 %id)
CD365135 Alveolar Macrophage, lung .d 572 to 1271 716 to 19   tiling clone, AAA   698/698
(100 %)
2 diff
(99.8 %id)
AW955217   .e 1 to 625 1 to 625   tiling clone,   625/625
(100 %)
2 diff
(99.7 %id)
TI_1948092448   .e 20 to 641 123 to 740   tiling clone, fully sequenced,   618/740
(83 %)
7 diff
(99.1 %id)
TI_1948092729   .e 21 to 641 124 to 740   fully sequenced,   617/740
(83 %)
7 diff
(99.1 %id)
TI_1948092578   .e 23 to 641 129 to 743   fully sequenced,   615/743
(82 %)
7 diff
(99.1 %id)
TI_1948092449   .e 611 to 1148 659 to 122   tiling clone, fully sequenced,   538/659
(81 %)
0 diff
(100 %id)
TI_1948092579   .e 611 to 1148 662 to 125   fully sequenced,   538/662
(81 %)
0 diff
(100 %id)
TI_1948092730   .e 611 to 1148 660 to 123   fully sequenced,   538/660
(81 %)
0 diff
(100 %id)
AA336559 endometrium .f 1 to 261 1 to 261   tiling clone,   261/261
(100 %)
0 diff
(100 %id)
BM755900 Ascites, stomach .f 130 to 737 1 to 607       607/607
(100 %)
2 diff
(99.7 %id)
BM783907 Ascites, stomach .f 130 to 785 1 to 655   tiling clone,   655/655
(100 %)
1 diff
(99.9 %id)
BM784923 Ascites, stomach .f 130 to 348 1 to 218       218/218
(100 %)
5 diff
(97.8 %id)
BM746878 Ascites, stomach .f 130 to 721 1 to 591       591/591
(100 %)
2 diff
(99.7 %id)
BM746880 Ascites, stomach .f 130 to 752 1 to 622       622/622
(100 %)
1 diff
(99.9 %id)
BM766582 Ascites, stomach .f 130 to 604 1 to 474       474/474
(100 %)
3 diff
(99.4 %id)
BM766324 Ascites, stomach .f 130 to 559 1 to 429       429/429
(100 %)
1 diff
(99.8 %id)
BG191627   .f 235 to 1004 778 to 12     Submitted on the opposite strand 767/872
(87 %)
9 diff
(99.0 %id)
BE618710 eye, retinoblastoma .f 245 to 957 734 to 3       728/734
(99 %)
33 diff
(95.6 %id)
CB529186 Aveolar Macrophage, lung .f 285 to 1012 746 to 19   AAA   728/728
(100 %)
0 diff
(100 %id)
BF219902 lung, small cell carcinoma .f 296 to 968 663 to 1       663/702
(94 %)
14 diff
(98.1 %id)
TI_151751039   .f 323 to 1015 755 to 68   AAA   688/693
(99 %)
8 diff
(98.9 %id)
BE728695 melanotic melanoma, skin .f 339 to 1011 1 to 683       683/1131
(60 %)
26 diff
(97.8 %id)
BQ000108 Fibrosarcoma .f 346 to 1022 695 to 19   tiling clone, AAA   677/677
(100 %)
2 diff
(99.8 %id)
BM999128 lung, Lung Focal Fibrosis .f 354 to 1018 683 to 19   AAA   665/665
(100 %)
2 diff
(99.7 %id)
AI580002 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f 356 to 1015 692 to 41   AAA   652/665
(98 %)
35 diff
(94.8 %id)
CR986406 T-Lymphocytes .f 360 to 1007 1 to 648       648/648
(100 %)
3 diff
(99.6 %id)
BU628452 cell lines, Chondrosarcoma .f 363 to 1015 671 to 19   AAA   653/653
(100 %)
1 diff
(99.9 %id)
BF112162 pooled .f 368 to 991 624 to 1       624/625
(99 %)
38 diff
(94.0 %id)
AW511554 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f 391 to 1013 625 to 3       623/625
(99 %)
6 diff
(99.1 %id)
R01534 liver and spleen .g 1 to 323 1 to 333   tiling clone,   333/347
(95 %)
28 diff
(92.0 %id)
R00875 liver and spleen .g 667 to 921 260 to 1   tiling clone,   260/367
(70 %)
10 diff
(97.3 %id)
BI197078 brain, neuroblastoma .h 1 to 750 1 to 741   tiling clone,   741/741
(100 %)
25 diff
(96.7 %id)
CR591445 HeLa cells Cot 25-normalized .i 1 to 1247 1 to 1247 exact tiling clone,   1247/1247
(100 %)
0 diff
(100 %id)
BX363415   .i 1 to 689 1 to 688   fully sequenced,   688/688
(100 %)
1 diff
(99.9 %id)
BG217107   .i 346 to 969 42 to 667       626/858
(72 %)
26 diff
(97.0 %id)
BG203887   .i 347 to 1133 1 to 782       782/869
(89 %)
15 diff
(98.3 %id)
BX363414   .i 628 to 1247 620 to 1   fully sequenced,   620/620
(100 %)
2 diff
(99.7 %id)
AI521670 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .i 807 to 1279 508 to 42   tiling clone, AAA   467/467
(100 %)
24 diff
(94.9 %id)
BQ691482 ductal carcinoma, cell line, Pancreas .j 1 to 885 1 to 893 I153L A158G D160G R161Q F162I ... tiling clone,   893/893
(100 %)
15 diff
(98.4 %id)
DR001715 fetal brain .k 1 to 805 9 to 813 exact tiling clone,   805/813
(99 %)
7 diff
(99.2 %id)
AL832249 endometrium carcinoma cell line .l 1 to 2450 1 to 2453 exact tiling clone, available from DKFZ, AAA   2453/2453
(100 %)
21 diff
(99.2 %id)
DA096159 cerebellum .l 2416 to 2941 2 to 526   tiling clone, capped   525/527
(99 %)
10 diff
(98.2 %id)
BE779110 eye, retinoblastoma .m 1 to 561 1 to 561   tiling clone,   561/789
(71 %)
14 diff
(98.3 %id)
BE798864 lung, small cell carcinoma .m 156 to 845 41 to 730 exact tiling clone,   690/731
(94 %)
8 diff
(99.0 %id)
BE782248 eye, retinoblastoma .n 1 to 706 1 to 699 F37L G38E G39V A40P N41T ... tiling clone,   699/927
(75 %)
12 diff
(98.8 %id)
FN084426 breast carcinoma .n 92 to 170 11 to 89       79/89
(88 %)
6 diff
(93.3 %id)
W52533 senescent fibroblast .o 1 to 575 25 to 601 K87* tiling clone,   577/602
(95 %)
13 diff
(97.9 %id)
AV696402 hepatocellular carcinoma .p 1 to 627 10 to 631 F67X tiling clone,   622/1030
(60 %)
22 diff
(97.9 %id)
BP872169 embryonal kidney .q 1 to 592 1 to 592 G53A R83G tiling clone,   592/592
(100 %)
4 diff
(99.4 %id)
BG563324 Liver .r-u 1 to 691 1 to 688 W6G Q7S Q9N S10L R11G ... tiling clone,   688/688
(100 %)
10 diff
(98.6 %id)
DB458852.
matches multiple genes
testis .s 1 to 448 1 to 448 exact tiling clone, also hits gene HSPA5 448/448
(100 %)
2 diff
(99.6 %id)
AW250303 lung, small cell carcinoma .s 19 to 422 7 to 410 R20K     404/410
(98 %)
2 diff
(99.6 %id)
BG107679 Bone, osteosarcoma, cell line .s 23 to 555 1 to 532 R67S S68A R69S R71A E72H ... tiling clone,   532/824
(64 %)
19 diff
(97.7 %id)
CN292951 embryonic stem cells, DMSO-treated H9 cellline .s 92 to 545 1 to 454   tiling clone,   454/455
(99 %)
4 diff
(99.2 %id)
AI420634 Prostate .t 1 to 465 470 to 6 exact tiling clone,   465/470
(98 %)
0 diff
(100 %id)
AI572824 Kidney .t 17 to 354 338 to 1 exact     338/338
(100 %)
0 diff
(100 %id)
AW949106 prostate_tumor .t 208 to 520 313 to 1   tiling clone, Submitted on the opposite strand 313/313
(100 %)
0 diff
(100 %id)
BF887724 testis_normal Gene RABEPK, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
BM311592 Pancreas, Purified pancreatic islet Gene RABEPK, variant not shown         This clone was ignored    
AV711548 adrenal cortico adenoma for Cushing'ssyndrome Gene RABEPK, variant not shown         Suspected internal deletion, this clone was ignored    
AA779398 whole brain Gene RABEPK, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AA742705 pooled germ cell tumors Gene RABEPK, variant not shown         Suspected internal deletion, this clone was ignored    
BE537501 cervix Gene RABEPK, variant not shown         This clone was ignored    
BG621627 placenta Gene RABEPK, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
BI603045 brain, hypothalamus Gene RABEPK, variant not shown         Suspected internal deletion, this clone was ignored    
CK821573 Pancreas, Purified pancreatic islet Gene RABEPK, variant not shown         Submitted on the opposite strand    
CK821574 Pancreas, Purified pancreatic islet Gene RABEPK, variant not shown       AAA Submitted on the opposite strand    
TI_45215798   Gene RABEPK, variant not shown         Suspected internal deletion, this clone was ignored    
BU622216 Cell Line, Chondrosarcoma Gene RABEPK, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r-u, .s, .t Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI